Azenta, Inc. (AZTA)
33.88
-2.64
(-7.23%)
USD |
NASDAQ |
Oct 16, 15:36
Azenta Research and Development Expense (Quarterly) : 8.853M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.853M |
| March 31, 2026 | 9.433M |
| December 31, 2025 | 9.189M |
| September 30, 2025 | 8.258M |
| June 30, 2025 | 7.417M |
| March 31, 2025 | 7.602M |
| December 31, 2024 | 7.113M |
| September 30, 2024 | 7.539M |
| June 30, 2024 | 6.911M |
| March 31, 2024 | 7.733M |
| December 31, 2023 | 7.313M |
| September 30, 2023 | 8.932M |
| June 30, 2023 | 8.968M |
| March 31, 2023 | 8.52M |
| December 31, 2022 | 7.536M |
| September 30, 2022 | 7.647M |
| June 30, 2022 | 6.515M |
| March 31, 2022 | 6.896M |
| December 31, 2021 | 6.485M |
| September 30, 2021 | 6.599M |
| June 30, 2021 | 5.489M |
| March 31, 2021 | 5.236M |
| December 31, 2020 | 5.088M |
| September 30, 2020 | 4.436M |
| June 30, 2020 | 13.60M |
| Date | Value |
|---|---|
| March 31, 2020 | 15.32M |
| December 31, 2019 | 13.30M |
| September 30, 2019 | 14.88M |
| June 30, 2019 | 14.24M |
| March 31, 2019 | 14.10M |
| December 31, 2018 | 13.15M |
| September 30, 2018 | 12.14M |
| June 30, 2018 | 12.04M |
| March 31, 2018 | 11.35M |
| December 31, 2017 | 11.40M |
| September 30, 2017 | 12.86M |
| June 30, 2017 | 11.96M |
| March 31, 2017 | 11.34M |
| December 31, 2016 | 10.84M |
| September 30, 2016 | 12.34M |
| June 30, 2016 | 12.82M |
| March 31, 2016 | 13.11M |
| December 31, 2015 | 13.28M |
| September 30, 2015 | 13.23M |
| June 30, 2015 | 12.13M |
| March 31, 2015 | 11.08M |
| December 31, 2014 | 12.09M |
| September 30, 2014 | 14.11M |
| June 30, 2014 | 12.29M |
| March 31, 2014 | 12.49M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 120.00M |
| Bio-Rad Laboratories, Inc. | 61.20M |
| Bruker Corp. | 94.30M |
| Danaher Corp. | 412.00M |
| Harvard Bioscience, Inc. | 2.453M |